secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibrx Biosciences, Inc. (INBX)
CIK:        0002007919
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0002007919-25-000063
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Inhibrx stockholders elect two Class I directors, ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Jon Faiz Kayyem, Ph.D. elected with 8,077,611 votes for, 31,060 withheld (3,384,613 broker non-votes).
- Kristiina Vuori, M.D., Ph.D. elected with 6,494,317 votes for, 1,614,354 withheld (3,384,613 broker non-votes).
- Ratification of BDO USA as auditor passed with 11,463,328 for, 2,918 against, 27,038 abstained.
- Quorum of 11,493,284 shares (79% of eligible) was present at the May 28, 2025 virtual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2007919/000200791925000063/0002007919-25-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2007919/000200791925000063/inhibrx-20250528.htm
  HTML page:      https://secwatch.observer/filing/0002007919-25-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer